iQure Receives Export Approval for Alzheimer's Treatment Patch
[Asia Economy Reporter Ji Yeon-jin] iCure announced on the 3rd that it has received export product approval from the Ministry of Food and Drug Safety for Donepezil patches, an Alzheimer's treatment.
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051914165468840_1779167814.png)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- "I'll Stop by Starbucks Tomorrow": People Power Chungbuk Committee and Geoje Mayoral Candidate Face Criticism for Alleged 5·18 Demeaning Remarks
- 59% of Americans Say "U.S. Prime Has Already Passed"... 44% Pessimistic About Next 50 Years
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
This patch is an improved new drug developed as a formulation that is applied twice a week, replacing the once-daily oral Donepezil medication for Alzheimer's disease patients.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
